Highlights of 2021


To showcase the high impact research published in Endocrine-Related Cancer, we have collated the most highly cited and downloaded reviews and research of the last year.

Explore the collection to make sure you haven’t missed the most popular and exciting articles!


Top 10 articles most cited in 2021, published in 2020


The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
Alastair Davies, Amina Zoubeidi, and Luke A Selth

PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Halfdan Sorbye, Grace Kong, and Simona Grozinsky-Glasberg

Redifferentiation of radioiodine-refractory thyroid cancers
Camille Buffet et al.

Neuroendocrine neoplasm update: toward universal nomenclature
Guido Rindi and Frediano Inzani

Thyroid cancer in the age of COVID-19
Venessa H M Tsang et al.

Androgen hazards with COVID-19
Nima Sharifi and Charles J Ryan

Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis
Thi-Van-Trinh Tran et al.

The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)
Maria P Yavropoulou et al.

COVID-19 and androgen-targeted therapy for prostate cancer patients
Neil A Bhowmick et al.

Molecular profiling for acromegaly treatment: a validation study
Manel Puig-Domingo et al.


Top 10 most-downloaded articles published in 2021


Follow-up of patients with thyroid cancer and antithyroglobulin antibodies: a review for clinicians
Pedro Weslley Rosario, Marina Carvalho Souza Côrtes, and Gabriela Franco Mourão

Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
Jonathan Nyce

Somatostatin receptor radionuclide therapy in neuroendocrine tumors
Mintallah Haider et al.

Therapy considerations in neuroendocrine prostate cancer: what next?
Himisha Beltran and Francesca Demichelis

50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?
V Craig Jordan

Usefulness of accessible imaging methods in thyroid nodules with indeterminate cytology
Pedro Weslley Rosario, Tiara Grossi Rocha, and Gabriela Franco Mourão

Tailoring the approach to radioactive iodine treatment in thyroid cancer
Sarah E Mayson, Christine M Chan, and Bryan R Haugen

The thyroid risk score (TRS) for nodules with indeterminate cytology
Carla Colombo et al.

Cancer clocks in tumourigenesis: the p53 pathway and beyond
Ewan M Stephenson et al.

Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
James C Yao et al.